Peptide Network:Peptides Looksmaxxing·Maxxing Peptides·Peptide Scientists
#1
Clav's Stack
>98%
HPLC Verified
Every Order
COA Included
24+
Products
$200+
Free Shipping
Always
3rd-Party Tested
Back to Products
GLP-1 Receptor Agonist
Semaglutide

GLP-1 Receptor Agonist

Buy Semaglutide

Not For Human Use, Lab Use Only.

GLP-1 receptor pharmacology—research-grade lyophilized material for laboratory inventory. Not a drug label or outcome summary.

Select size

$44.99In Stock
Buy Semaglutide 3mg

≥98% Purity

HPLC Verified

Research Grade

Lyophilized

Fast Shipping

Free $200+

Specifications

CAS Number910463-68-2
MechanismGLP-1 receptor agonist
Molecular Weight~4,113 Da
Half-life~7 days (enables weekly dosing)
Storage−20°C (lyophilized) · 4°C in solution up to 4 weeks
Purity≥98% HPLC verified

Semaglutide — What the Compound Does in the Cell

M1

Hypothalamic Appetite Suppression

Semaglutide engages GLP-1 receptors in central circuits discussed in pharmacology references (including hypothalamic and brainstem regions). This catalog does not restate human neuroimaging or feeding-behavior outcomes.

M2

Gastric Emptying Delay

GLP-1 receptor activation slows gastric emptying, extending the feeling of fullness after meals. This mechanical satiety effect operates independently of appetite suppression, providing dual control of caloric intake.

M3

Glucose-Dependent Insulin Potentiation

Semaglutide potentiates insulin secretion from pancreatic beta cells in a glucose-dependent manner — meaning it only increases insulin when blood glucose is elevated, reducing hypoglycemia risk. It also suppresses inappropriate glucagon secretion.

M4

Cardiometabolic Literature (High Level)

Cardiovascular outcome studies exist for marketed GLP-1 medicines. This catalog page does not summarize hazard ratios, event rates, or regulatory indications.

Semaglutide — Research-Use Notice

This page summarizes identity, purity, and handling context for catalog navigation. It is not medical advice, a drug label, or a summary of clinical outcomes for any use. Materials are sold for legitimate laboratory research only; verify requirements with your institution and the supplier.

Buying Semaglutide: Reconstitution Reference

Figures below are volumetric / handling notes for lyophilized material only. They are not therapeutic dosing, efficacy claims, or instructions for use in humans or animals.

Protocol
Dose
Frequency
Notes
Standard Weekly Injection
0.25–2.4 mg/week
Once weekly
Illustrative weekly titration ladders appear in public drug labels—shown here only as a volumetric reference for dissolved material, not instructions.
Low Entry Point
0.25 mg/week
Once weekly for 4 weeks, then escalate
Lower starting strengths are discussed in many publications for tolerability—reference only.
Compound note

Semaglutide — Vial-Specific Reconstitution

5mg vial + 2mL BAC water = 2.5mg/mL. Example draws: 0.2mL = 0.5mg; 0.96mL = 2.4mg—math for solution prep only.

Semaglutide's fatty-acid tail can cause it to dissolve slower than smaller peptides — allow 3–5 min of gentle swirling. Post-reconstitution stable at 2–8°C for 4 weeks.

Semaglutide — Co-Administered Peptides

BPC-157

BPC-157 is ordered alongside many metabolic SKUs for separate mucosal-repair research tracks.

GHK-Cu

GHK-Cu is a common add-on for dermal-matrix studies unrelated to GLP-1 pharmacology.

Semaglutide

from $44.99

Shop Now